arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

Pluri Inc.

PLUR
$1.56 0.00 (0.00%) at close
Healthcare ·Biological Products, (No Diagnostic Substances) ·USBiological Products, (No Diagnostic Substances)
65 Visible periods
27 Metrics
Absolute Benchmarks
Price Chart
38
Health
Weak
Moderately Bullish Absolute basis
auto_awesome

Analytical Summary

On an absolute basis, Pluri Inc. shows strong fundamentals, led by Return on Invested Capital. Watch FCF / Net Income against typical quality thresholds. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $15.7M
Dividend Yield
Revenue Growth -60.9%
Op. Margin None
ROIC 35.1%
FCF / Share $-0.45
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 4, 2026.

65-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$167.00K
↓ -60.9%
Net Income Profit after all expenses
$-5.55M
↑ +9.7%
FCF / Share Free cash flow per share
$-0.45
↑ +39.1%

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

  • Return on Invested CapitalReturn on Invested Capital of 324.0% is excellent on an absolute basis (target > 10%)
warning

Bearish Risks

  • FCF / Net IncomeFCF / Net Income of 0.88x is caution on an absolute basis (target > 1x)

Health Breakdown

Cash Quality
38

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 17 years · 65 quarters